Related Experiment Video
Updated: Dec 3, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery
Satoru Suzuki1, Koichi Kaikita2, Eiichiro Yamamoto1
1Department of Cardiovascular Medicine and Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Insights
Coronary artery spasm is a key cause of nonobstructive coronary artery disease (CAD) and angina. The acetylcholine (ACh) provocation test aids in diagnosing coronary spasm, guiding treatment for patients with suspected CAD.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Vascular Medicine
Background:
- Nonobstructive coronary artery disease (CAD) is increasingly recognized in patients presenting with angina or acute coronary syndrome (ACS).
- Coronary artery spasm is a significant contributor to both stable angina and ACS in the absence of obstructive epicardial coronary stenosis.
- Coronary spasm can lead to left ventricular dysfunction and heart failure, potentially responsive to calcium channel blockers.
Purpose of the Study:
- To highlight the diagnostic utility of the acetylcholine (ACh) provocation test in identifying coronary artery spasm.
- To emphasize the role of the ACh provocation test in managing patients with nonobstructive CAD.
- To explore the ACh provocation test's applicability in assessing microvascular spasm and dysfunction.
Main Methods:
- Invasive coronary angiography (CAG) with acetylcholine (ACh) provocation testing.
- Assessment of coronary artery spasm during CAG.
- Evaluation of microvascular function and spasm.
Main Results:
- The ACh provocation test is effective in detecting coronary artery spasm, a common cause of nonobstructive CAD.
- The test can identify high-risk patients with coronary spasm and concomitant organic coronary stenosis.
- ACh provocation testing may also aid in assessing microvascular spasm or dysfunction.
Conclusions:
- The acetylcholine (ACh) provocation test is a valuable tool for diagnosing coronary artery spasm in patients with nonobstructive coronary artery disease (CAD).
- This invasive diagnostic modality can guide treatment strategies, including the use of calcium channel blockers, and identify high-risk individuals.
- Increased utilization of the ACh provocation test by cardiologists is recommended for a comprehensive assessment of nonobstructive CAD pathophysiology.
Abstract:
Coronary angiography (CAG) sometimes shows nonobstructive coronary arteries in patients with suspected angina or acute coronary syndrome (ACS). The high prevalence of nonobstructive coronary artery disease (CAD) in those patients has recently been reported not only in Japan but also in Western countries, and is clinically attracting attention. Coronary spasm is considered to be one of the leading causes of both suspected stable angina and ACS with nonobstructive coronary arteries. Coronary spasm could also be associated with left ventricular dysfunction leading to heart failure, which could be improved following the administration of calcium channel blockers. Because we rarely capture spontaneous attacks of coronary spasm with electrocardiograms or Holter recordings, an invasive diagnostic modality, acetylcholine (ACh) provocation test, can be useful in detecting coronary spasm during CAG. Furthermore, we can use the ACh-provocation test to identify high-risk patients with coronary spasm complicated with organic coronary stenosis, and then treat with intensive care. Nonobstructive CAD includes not only epicardial coronary spasm but also microvascular spasm or dysfunction that can be associated with recurrent anginal attacks and poor quality of life. ACh-provocation test could also be helpful for the assessment of microvascular spasm or dysfunction. We hope that cardiologists will increasingly perform ACh-provocation test to assess the pathophysiology of nonobstructive CAD.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome I: Introduction

